Pharmasset, Inc (vrus) - Financial And Strategic Analysis Review - Aarkstore Enterprise

Aarkstore announce a new report " Pharmasset

, Inc (VRUS) - Financial and Strategic Analysis Review " through its vast collection of market research report.

Pharmasset, Inc. (Pharmasset) is a publicly held US-based biopharmaceutical company. It is principally engaged in discovering, developing and commercializing drugs to treat viral infections. The company is focused on the development of oral therapeutics used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Its research and development activities are focused on a class of compounds known as nucleoside analogs, which act to inhibit the natural enzymes required for viral replication. The company's product portfolio comprises of RG7128, PSI-879, PSI-7977, and PSI-938.

Pharmasset, Inc Key Recent Developments

Apr 08, 2010: Pharmasset Initiates Dosing In Phase 1 PSI-938 Trial

Feb 18, 2010: Roche Completes Enrollment Of RG7128 Phase 2b Clinical Study

Nov 23, 2009: Pharmasset Continues Enrollment In Phase 2b Clinical Trial Of RG7128

Aug 10, 2009: Pharmasset Reports Revenue Of $10.5m For Q3

Jul 31, 2009: Pharmasset Reports Positive Preliminary Antiviral Data For PSI-7851

This comprehensive SWOT profile of Pharmasset, Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pharmasset, Inc, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/Pharmasset-Inc-VRUS-Financial-and-Strategic-Analysis-Review-50295.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

Pharmasset, Inc (vrus) - Financial And Strategic Analysis Review - Aarkstore Enterprise

Aarkstore announce a new report " Pharmasset

Contact

www.yloan.com

Products

Our Solutions

Press Room

Resources